// App-Quantinova.ai

1693 : Nicotinamide N-methyltransferase in clear cell renal cell carcinoma primary tumors and metastases

Researchers

Presenter

  • Anna Reustle

Principal Investigators

  • Steffen Rausch

  • Stefan Winter

  • Florian Buttner

  • Stephan Kruck

  • Joerg Hennenlotter

  • Marcus Scharpf

  • Falko Fend

  • Jens Bedke

  • Arnulf Stenzl

  • Matthias Schwab

  • Elke Schaeffeler

Medical Centers

  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tubingen, Stuttgart, Germany

  • Department of Radiation Oncology, University Hospital Tubingen, Tuebingen, Germany

  • Institute of Pathology and Neuropathology, University Hospital Tubingen, Tubingen, Germany.

  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and Department of Clinical Pharmacology, University Hospital Tuebingen, Stuttgart, Germany.

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

  • Solid malignancies

Biomarkers

  • Nicotinamide N-methyltransferase

Drug/Treatment

  • Nicotinamide

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved